Your browser doesn't support javascript.
loading
Corrigendum to "Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation" [Clin Microbiol Infect 28 (12) (2022 Dec) 1657-1658].
Antonelli, Guido; Focosi, Daniele; Turriziani, Ombretta; Tuccori, Marco; Brandi, Rossella; Fillo, Silvia; Ajassa, Camilla; Lista, Florigio; Mastroianni, Claudio M.
Afiliação
  • Antonelli G; Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
  • Turriziani O; Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Tuccori M; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, Unit of Adverse Drug Reactions Monitoring, Pisa University Hospital, Pisa, Italy.
  • Brandi R; Scientific Department, Army Medical Center, Rome, Italy.
  • Fillo S; Scientific Department, Army Medical Center, Rome, Italy.
  • Ajassa C; Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
  • Lista F; Scientific Department, Army Medical Center, Rome, Italy.
  • Mastroianni CM; Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
Clin Microbiol Infect ; 30(3): 408, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38103639

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália